We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Woodward (WWD) to Report Q1 Earnings: What's in the Cards?
Read MoreHide Full Article
Woodward, Inc. (WWD - Free Report) is scheduled to report first-quarter fiscal 2020 results on Feb 3, after the closing bell. In the last reported quarter, the company delivered a negative earnings surprise of 5.4%. Woodward topped the Zacks Consensus Estimate for earnings thrice in the trailing four quarters, the beat being 17.2%, on average.
The Fort Collins, CO-based company is expected to have recorded higher aggregate revenues on a year-over-year basis, led by strong product portfolio and healthy market fundamentals in the Aerospace segment.
The Zacks Consensus Estimate for net sales at Aerospace, which accounts for the lion’s share of total revenues, is pegged at $408 million. This indicates a rise of 3.8% from the year-ago quarter’s reported figure. The segment is likely to have gained from higher defense spending and increase in aircraft content. The consensus estimate for net sales at the Industrial segment is pegged at $256 million, suggesting a decline of 1.5% from the prior-year quarter’s recorded figure, due to demand-related challenges.
For the December quarter, the consensus estimate for total revenues stands at $667 million, implying an increase of 2.1% from the year-ago quarter’s reported figure. Consequently, adjusted earnings per share are pegged at $1.03, indicating a rise of 7.3% from the prior-year quarter’s reported figure.
What Our Model Says
Our proven model doesn’t conclusively predict an earnings beat for Woodward this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Woodward’s Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is 0.00% as both are pegged at $1.03.
Zacks Rank: Woodward currently has a Zacks Rank #3.
Stocks to Consider
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Royal Gold, Inc. (RGLD - Free Report) is scheduled to release results on Feb 5. The company has an Earnings ESP of +0.78% and sports a Zacks Rank #1.
NGL Energy Partners LP (NGL - Free Report) has an Earnings ESP of +36.84% and sports a Zacks Rank of 1. The company is set to report results on Feb 6.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Woodward (WWD) to Report Q1 Earnings: What's in the Cards?
Woodward, Inc. (WWD - Free Report) is scheduled to report first-quarter fiscal 2020 results on Feb 3, after the closing bell. In the last reported quarter, the company delivered a negative earnings surprise of 5.4%. Woodward topped the Zacks Consensus Estimate for earnings thrice in the trailing four quarters, the beat being 17.2%, on average.
The Fort Collins, CO-based company is expected to have recorded higher aggregate revenues on a year-over-year basis, led by strong product portfolio and healthy market fundamentals in the Aerospace segment.
The Zacks Consensus Estimate for net sales at Aerospace, which accounts for the lion’s share of total revenues, is pegged at $408 million. This indicates a rise of 3.8% from the year-ago quarter’s reported figure. The segment is likely to have gained from higher defense spending and increase in aircraft content. The consensus estimate for net sales at the Industrial segment is pegged at $256 million, suggesting a decline of 1.5% from the prior-year quarter’s recorded figure, due to demand-related challenges.
For the December quarter, the consensus estimate for total revenues stands at $667 million, implying an increase of 2.1% from the year-ago quarter’s reported figure. Consequently, adjusted earnings per share are pegged at $1.03, indicating a rise of 7.3% from the prior-year quarter’s reported figure.
What Our Model Says
Our proven model doesn’t conclusively predict an earnings beat for Woodward this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Woodward’s Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is 0.00% as both are pegged at $1.03.
Woodward, Inc. Price and EPS Surprise
Woodward, Inc. price-eps-surprise | Woodward, Inc. Quote
Zacks Rank: Woodward currently has a Zacks Rank #3.
Stocks to Consider
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Microchip Technology Incorporated (MCHP - Free Report) is slated to release quarterly results on Feb 4. It has an Earnings ESP of +1.33% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Royal Gold, Inc. (RGLD - Free Report) is scheduled to release results on Feb 5. The company has an Earnings ESP of +0.78% and sports a Zacks Rank #1.
NGL Energy Partners LP (NGL - Free Report) has an Earnings ESP of +36.84% and sports a Zacks Rank of 1. The company is set to report results on Feb 6.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>